Education
About Us
Working with TipRanks
Follow Us
Hofseth Biocare ASA (HOFBF)
OTHER OTC:HOFBF
HOFBF Stock Chart & Stats
$0.17
$0.00(0.00%)
At close: 4:00 PM EST
$0.17
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.10 - $0.17
Previous CloseN/A
Volume21.20K
Average Volume (3M)0.00
Market Cap
$52.37M
Enterprise Value$944.88M
Total Cash (Recent Filing)$71.95M
Total Debt (Recent Filing)$236.19M
Price to Earnings (P/E)―
Beta-0.28
Next Earnings
Feb 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding395,081,020
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap18.04
Enterprise Value/Revenue3.45
Enterprise Value/Gross Profit10.96
Enterprise Value/Ebitda-13.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hofseth Biocare ASA News
HOFBF FAQ
What was Hofseth Biocare ASA’s price range in the past 12 months?
Hofseth Biocare ASA lowest stock price was $0.10 and its highest was $0.17 in the past 12 months.
What is Hofseth Biocare ASA’s market cap?
Hofseth Biocare ASA’s market cap is $52.37M.
When is Hofseth Biocare ASA’s upcoming earnings report date?
Hofseth Biocare ASA’s upcoming earnings report date is Feb 13, 2026 which is in 59 days.
How were Hofseth Biocare ASA’s earnings last quarter?
Hofseth Biocare ASA released its earnings results on Nov 07, 2025. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
Is Hofseth Biocare ASA overvalued?
According to Wall Street analysts Hofseth Biocare ASA’s price is currently Overvalued.
Does Hofseth Biocare ASA pay dividends?
Hofseth Biocare ASA does not currently pay dividends.
What is Hofseth Biocare ASA’s EPS estimate?
Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hofseth Biocare ASA have?
Hofseth Biocare ASA has 395,081,020 shares outstanding.
What happened to Hofseth Biocare ASA’s price movement after its last earnings report?
Hofseth Biocare ASA reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hofseth Biocare ASA?
Currently, no hedge funds are holding shares in HOFBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hofseth Biocare ASA
Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.
Technical Analysis
Ownership Overview
―
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---